Picture of Synaptogenix logo

SNPX Synaptogenix Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Synaptogenix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-15.1-12.7-12.6-5.57-6.04
Depreciation
Non-Cash Items5.613.93.87-5.030.501
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2.370.6940.026-0.6150.358
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-11.9-8.1-8.71-11.2-5.17
Capital Expenditures-0.005-0.005-0.003-0.007-0.003
Purchase of Fixed Assets
Other Investing Cash Flow Items-2
Purchase of Investments
Cash from Investing Activities-0.005-0.005-0.003-0.007-2
Financing Cash Flow Items-20-0.0020
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Cash from Financing Activities0.42-3.4837.114.5-1.64
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-11.5-11.628.43.26-8.82